Takuma Hashimoto

5.2k total citations
164 papers, 3.5k citations indexed

About

Takuma Hashimoto is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Takuma Hashimoto has authored 164 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Molecular Biology and 28 papers in Physiology. Recurrent topics in Takuma Hashimoto's work include Thyroid Cancer Diagnosis and Treatment (22 papers), Asthma and respiratory diseases (19 papers) and Thyroid Disorders and Treatments (15 papers). Takuma Hashimoto is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (22 papers), Asthma and respiratory diseases (19 papers) and Thyroid Disorders and Treatments (15 papers). Takuma Hashimoto collaborates with scholars based in Japan, United States and Zambia. Takuma Hashimoto's co-authors include Shin‐ichi Fujita, Takatoshi Michigishi, Yumie Kamio, Akitaka Nonomura, Fujitsugu Matsubara, Masakuni Noguchi, Yuko Nanbu, Yuji Wada, Yuji Mizukami and Yasuko Senda and has published in prestigious journals such as New England Journal of Medicine, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Takuma Hashimoto

161 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuma Hashimoto Japan 34 845 790 559 541 370 164 3.5k
Yasushi Kawakami Japan 35 378 0.4× 1.1k 1.4× 252 0.5× 424 0.8× 526 1.4× 192 3.6k
Satoru Suzuki Japan 31 1.0k 1.2× 809 1.0× 231 0.4× 409 0.8× 534 1.4× 240 3.7k
Joan Valls Spain 26 262 0.3× 1.1k 1.4× 342 0.6× 329 0.6× 329 0.9× 89 3.6k
Timothy G. Hammond United States 38 312 0.4× 2.1k 2.7× 424 0.8× 1.2k 2.2× 359 1.0× 126 4.7k
Maki Goto Japan 37 758 0.9× 1.2k 1.5× 102 0.2× 369 0.7× 438 1.2× 172 5.3k
H. Schneider Switzerland 42 192 0.2× 895 1.1× 496 0.9× 278 0.5× 426 1.2× 152 5.2k
Kazuhiro Abe Japan 34 216 0.3× 1.7k 2.1× 339 0.6× 431 0.8× 614 1.7× 300 4.8k
Kenji Saito Japan 36 211 0.2× 1.7k 2.2× 210 0.4× 607 1.1× 340 0.9× 234 5.2k
Koji Takada Japan 34 187 0.2× 1.8k 2.3× 285 0.5× 332 0.6× 384 1.0× 217 4.9k
Yuji Ueno Japan 40 322 0.4× 1.5k 1.9× 515 0.9× 491 0.9× 266 0.7× 277 5.8k

Countries citing papers authored by Takuma Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Takuma Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuma Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuma Hashimoto more than expected).

Fields of papers citing papers by Takuma Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuma Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuma Hashimoto. The network helps show where Takuma Hashimoto may publish in the future.

Co-authorship network of co-authors of Takuma Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Takuma Hashimoto. A scholar is included among the top collaborators of Takuma Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuma Hashimoto. Takuma Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Takuma, et al.. (2025). Oxamate, an LDHA Inhibitor, Inhibits Stemness, Including EMT and High DNA Repair Ability, Induces Senescence, and Exhibits Radiosensitizing Effects in Glioblastoma Cells. International Journal of Molecular Sciences. 26(12). 5710–5710. 2 indexed citations
2.
Hashimoto, Takuma, et al.. (2025). FDX1 Regulates the Phosphorylation of ATM, DNA-PKcs Akt, and EGFR and Affects Radioresistance Under Severe Hypoxia in the Glioblastoma Cell Line T98G. International Journal of Molecular Sciences. 26(7). 3378–3378. 2 indexed citations
3.
Hisaoka, Miharu, Tetsuro Komatsu, Takuma Hashimoto, et al.. (2025). Function of HP1BP3 as a linker histone is regulated by linker histone chaperones, NPM1 and TAF-I. Epigenetics & Chromatin. 18(1). 14–14. 1 indexed citations
4.
5.
Urushihara, Yusuke, Takuma Hashimoto, Yohei Fujishima, & Yoshio Hosoi. (2023). AMPK/FOXO3a Pathway Increases Activity and/or Expression of ATM, DNA-PKcs, Src, EGFR, PDK1, and SOD2 and Induces Radioresistance under Nutrient Starvation. International Journal of Molecular Sciences. 24(16). 12828–12828. 4 indexed citations
6.
Hashimoto, Takuma, et al.. (2021). BASE SHEAR COEFFICIENT OF MEDIUM AND LOW-RISE STEEL STRUCTURE BASED ON ENERGY BALANCE FOR CONTINUOUS USE AFTER EARTHQUAKE. Journal of Structural and Construction Engineering (Transactions of AIJ). 86(784). 893–900. 2 indexed citations
7.
Hashimoto, Takuma, et al.. (2021). AMPK increases expression of ATM through transcriptional factor Sp1 and induces radioresistance under severe hypoxia in glioblastoma cell lines. Biochemical and Biophysical Research Communications. 590. 82–88. 16 indexed citations
8.
Shi, Guoyu, Takuma Hashimoto, Donald A. Tryk, et al.. (2021). Enhanced oxygen reduction electrocatalysis on PtCoSn alloy nanocatalyst mediated by Ta-doped SnO2 support for polymer electrolyte fuel cells. Electrochimica Acta. 390. 138894–138894. 14 indexed citations
9.
10.
Hashimoto, Takuma, et al.. (2020). Synthesis and fluorescence photoswitching of a diarylethene derivative having a dibenzoylmethanato boron difluoride complex. Tetrahedron Letters. 61(29). 152108–152108. 6 indexed citations
11.
12.
Myou, Shigeharu, Masaki Fujimura, Yumie Kamio, et al.. (2000). Effect of Losartan, a Type 1 Angiotensin II Receptor Antagonist, on Bronchial Hyperresponsiveness to Methacholine in Patients with Bronchial Asthma. American Journal of Respiratory and Critical Care Medicine. 162(1). 40–44. 24 indexed citations
13.
Myou, Shigeharu, Masaki Fujimura, Yumie Kamio, et al.. (1999). Bronchodilator Effect of Inhaled Olprinone, a Phosphodiesterase 3 Inhibitor, in Asthmatic Patients. American Journal of Respiratory and Critical Care Medicine. 160(3). 817–820. 44 indexed citations
14.
Fujimura, Masaki, Miki Abo, Yumie Kamio, et al.. (1999). Effect of Leukotriene and Thromboxane Antagonist on Propranolol-induced Bronchoconstriction. American Journal of Respiratory and Critical Care Medicine. 160(6). 2100–2103. 11 indexed citations
15.
16.
Morishita, Eriko, Hidesaku Asakura, Hiroshi Jokaji, et al.. (1996). Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis. 120(1-2). 7–14. 49 indexed citations
17.
Fujimura, M, et al.. (1995). Bronchodilator and Bronchoprotective Effects of Cilostazol in Humans In Vivo. American Journal of Respiratory and Critical Care Medicine. 151(1). 222–225. 29 indexed citations
18.
Fujimura, Masaki, Yumie Kamio, Tamotsu Matsuda, & Takuma Hashimoto. (1993). Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects. Clinical Autonomic Research. 3(1). 31–35. 1 indexed citations
19.
Mizukami, Yusuke, Takatoshi Michigishi, Akitaka Nonomura, et al.. (1993). Mixed medullary‐follicular carcinoma of the thyroid occurring in familial form. Histopathology. 22(3). 284–287. 26 indexed citations
20.
Hashimoto, Takuma, Haruo Hisazumi, K. Nakajima, & F Matsubara. (1991). Studies on endocrine changes induced by 8 MHz local radiofrequency hyperthermia in patients with bladder cancer. International Journal of Hyperthermia. 7(4). 551–557. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Kawakami Breakdown of academic impact, for papers by Satoru Suzuki Breakdown of academic impact, for papers by Joan Valls Breakdown of academic impact, for papers by Timothy G. Hammond Breakdown of academic impact, for papers by Maki Goto Breakdown of academic impact, for papers by H. Schneider Breakdown of academic impact, for papers by Kazuhiro Abe Breakdown of academic impact, for papers by Kenji Saito Breakdown of academic impact, for papers by Koji Takada Breakdown of academic impact, for papers by Yuji Ueno
Rankless by CCL
2026